Loading...
Goodness Growth Holdings, Inc.
GDNS.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.63
CA$0.00(0.00%)

Over the past four quarters, Goodness Growth Holdings, Inc. demonstrated steady revenue growth, increasing from $20.20M in Q2 2023 to $23.98M in Q1 2024. Operating income reached $4.74M in Q1 2024, maintaining a consistent 20% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $4.99M, reflecting operational efficiency. Net income dropped to -$6.68M, with EPS at -$0.05. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan